Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Endocrine Disorders
Published in: BMC Endocrine Disorders 1/2023

Open Access 06-07-2023 | Hyperparathyroidism | Case report

Selective venous sampling in primary hyperparathyroidism caused by ectopic parathyroid gland: a case report and literature review

Authors: Xubin Yang, Xueyan Chen, Huan Xu, Junwei Chen, Bin Yao, Qiongyan Lin, Hongrong Deng, Wen Xu

Published in: BMC Endocrine Disorders | Issue 1/2023

Login to get access

Abstract

Background

As an invasive technique, selective venous sampling (SVS) is considered a useful method to identify a lesion’s location to increase the success rate of secondary surgery in patients with primary hyperparathyroidism (pHPT) caused by ectopic parathyroid adenomas.

Case presentation

We present a case of post-surgical persistent hypercalcemia and elevated parathyroid hormone (PTH) levels in a 44-year-old woman with previously undetected parathyroid adenoma. An SVS was then performed for further localization of the adenoma, as other non-invasive methods showed negative results. After SVS, an ectopic adenoma was suspected in the sheath of the left carotid artery, previously considered as a schwannoma, and was pathologically confirmed after the second operation. Postoperatively, the patient’s symptoms disappeared and serum levels of PTH and calcium normalized.

Conclusions

SVS can provide precise diagnosis and accurate positioning before re-operation in patients with pHPT.
Literature
1.
2.
Civelek AC, Ozalp E, Donovan P, et al. Prospective evaluation of delayed technetium-99m sestamibi SPECT scintigraphy for preoperative localization of primary hyperparathyroidism. Surgery. 2002;131:149–57.PubMedCrossRef
3.
Suntornlohanakul O, Leelawattana R. A case report of successful identification of ectopic parathyroid adenomas with a sequence of selective parathyroid venous sampling and 4D-computed tomography in a patient with recurrent hyperparathyroidism. Int J Surg Case Rep. 2020;71:183–6.PubMedPubMedCentralCrossRef
4.
5.
Binnetoğlu A, Demir B, Mamadlı J. Challenges in the management of ectopic parathyroid pathologies: a case series of five patient. Turk Arch Otorhinolaryngol. 2020;58:133–6.PubMedPubMedCentralCrossRef
6.
Kim J, Cubangbang M, Adkins L, et al. Ectopic parathyroid adenoma in the pyriform sinus. Head Neck. 2017;39:E110–3.PubMedCrossRef
7.
Ciappuccini R, Morera J, Pascal P, et al. Dual-phase 99mTc sestamibi scintigraphy with neck and thorax SPECT/CT in primary hyperparathyroidism: a single-institution experience. Clin Nucl Med. 2012;37:223–8.PubMedCrossRef
8.
Rubello D, Casara D, Giannini S, et al. Minimally invasive radioguided parathyroidectomy: an attractive therapeutic option for elderly patients with primary hyperparathyroidism. Nucl Med Commun. 2004;25:901–8.PubMedCrossRef
9.
10.
Asghar A, Ikram M, Islam N. A case report: Giant cystic parathyroid adenoma presenting with parathyroid crisis after Vitamin D replacement. BMC Endocr Disord. 2012;12:14.PubMedPubMedCentralCrossRef
11.
Hessman O, Stalberg P, Sundin A, et al. High success rate of parathyroid reoperation may be achieved with improved localization diagnosis. World J Surg. 2008;32:774–81.PubMedCrossRef
12.
13.
Westra WH, Pritchett DD, Udelsman R. Intraoperative confirmation of parathyroid tissue during parathyroid exploration: a retrospective evaluation of the frozen section. Am J Surg Pathol. 1998;22(5):538–44.PubMedCrossRef
14.
Norman J, Lopez J, Politz D. Abandoning unilateral parathyroidectomy: why we reversed our position after 15,000 parathyroid operations. J Am Coll Surg. 2012;214(3):260–9.PubMedCrossRef
15.
Udelsman R. Approach to the patient with persistent or recurrent primary hyperparathyroidism. J Clin Endocrinol Metab. 2011;96:2950–8.PubMedCrossRef
16.
Venkat R, Kouniavsky G, Tufano RP, et al. Long-term outcome in patients with primary hyperparathyroidism who underwent minimally invasive parathyroidectomy. World J Surg. 2012;36:55–60.PubMedCrossRef
17.
Yeh MW, Wiseman JE, Chu SD, et al. Population-level predictors of persistent hyperparathyroidism. Surgery. 2011;150:1113–9.PubMedCrossRef
18.
Guerin C, Paladino NC, Lowery A, et al. Persistent and recurrent hyperparathyroidism. Updates Surg. 2017;69:161–9.PubMedCrossRef
19.
Nilsson BE, Tisell LE, Jansson S, et al. Parathyroid localization by catheterization of large cervical and mediastinal veins to determine serum concentrations of intact parathyroid hormone. World J Surg. 1994;18:605–10.PubMedCrossRef
20.
Gilat H, Cohen M, Feinmesser R, et al. Minimally invasive procedure for resection of a parathyroid adenoma: the role of preoperative high-resolution ultrasonography. J Clin Ultrasound. 2005;33:283–7.PubMedCrossRef
21.
Kukar M, Platz TA, Schaffner TJ, et al. The use of modified four-dimensional computed tomography in patients with primary hyperparathyroidism: an argument for the abandonment of routine Sestamibi Single-Positron Emission Computed Tomography (SPECT). Ann Surg Oncol. 2014;22:139–45.PubMedCrossRef
22.
Koljevic Markovic A, Jankovic MM, Markovic I, et al. Parathyroid dual tracer subtraction scintigraphy: small regions method for quantitative assessment of parathyroid adenoma uptake. Ann Nucl Med. 2014;28:736–45.PubMedCrossRef
23.
Zanocco KA, Yeh MW. Primary hyperparathyroidism: effects on bone health. Endocrinol Metab Clin North Am. 2017;46:87–104.PubMedCrossRef
24.
Rotstein L, Irish J, Gullane P, et al. Reoperative parathyroidectomy in the era of localization technology. Head Neck. 1998;20:535–9.PubMedCrossRef
25.
Chen CC, Skarulis MC, Fraker DL, et al. Technetium-99m-sestamibi imaging before reoperation for primary hyperparathyroidism. J Nucl Med. 1995;36:2186–91.PubMed
26.
Fayet P, Hoeffel C, Fulla Y, et al. Technetium-99m sestamibi scintigraphy, magnetic resonance imaging and venous blood sampling in persistent and recurrent hyperparathyroidism. Br J Radiol. 1997;70:459–64.PubMedCrossRef
27.
Numerow LM, Morita ET, Clark OH, et al. Persistent/recurrent hyperparathyroidism a comparison of sestamibi scintigraphy, MRI, and ultrasonography. J Magn Reson Imaging. 1995;5:702–8.PubMedCrossRef
28.
Witteveen JE, Kievit J, van Erkel AR, et al. The role of selective venous sampling in the management of persistent hyperparathyroidism revisited. Eur J Endocrinol. 2010;163:945–52.PubMedCrossRef
29.
Seki K, Hashimoto K, Hisada T, et al. A patient with classic severe primary hyperparathyroidism in whom both Tc-99m MIBI scintigraphy and FDG-PET failed to detect the parathyroid tumor. Intern Med. 2004;43:816–23.PubMedCrossRef
30.
Wd L, Kt R, Jo D, et al. Parathyroid adenomas without sestamibi retention. Clin Nucl Med. 1995;20:699–702.CrossRef
31.
Jd R, Rb S, Sc S, et al. Comparison of Tc99m MIBI and Tl-201Tc-99m pertechnetate for diagnosis of primary hyperparathyroisidsm. Clin Nucl Med. 1996;21:602–8.CrossRef
32.
Schachter PP, Issa N, Shimonov M, et al. Early, postinjection MIBI-SPECT as the only preoperative localizing study for minimally invasive parathyroidectomy. Arch Surg. 2004;139(4):433–7.PubMedCrossRef
33.
Jaskowiak N, Norton JA, Alexander HR, et al. A prospective trial evaluating a standard approch to reoperation for missed parathyroid adenoma. Ann Surg. 1996;224:308–20.PubMedPubMedCentralCrossRef
34.
Mundschenk J, Klose S, Lorenz K, et al. Diagnostic strategies and surgical procedures in persistent or recurrent primary hyperparathyroidism. Exp Clin Endocrinol Diabetes. 1999;107:331–6.PubMedCrossRef
35.
Thompson GB, Grant CS, Perrier ND, et al. Reoperative parathyroid surgery in the era of sestamibi scanning and intraoperative parathyroid hormone monitoring. Arch Surg. 1999;34:699–704.CrossRef
36.
Moretti JL, Hauet N, Caglar M, et al. To use MIBI or not to use MIBI? That is the question when assessing tumour cells. Eur J Nucl Med Mol Imaging. 2005;32:836–42.PubMedCrossRef
37.
Piwnica-Worms DP, Kronauge JF, LeFurgey A, et al. Mitochondrial localization and characterization of 99Tc-SESTAMIBI in heart cells by electron probe X-ray microanalysis and 99Tc-NMR spectroscopy. Magn Reson Imaging. 1994;12:641–52.PubMedCrossRef
38.
Russell CF, Edis AJ, Scholz DA, et al. Mediastinal parathyroid tumors experience with 38 tumors requiring mediastinotomy for removal. Ann Surg. 1981;193:805–9.PubMedPubMedCentralCrossRef
39.
Estella E, Leong MSZ, Bennett I, et al. Parathyroid hormone venous sampling prior to reoperation for primary hyperparathyroidism. ANZ J Surg. 2003;73:800–5.PubMedCrossRef
40.
Jones JJ, Brunaud L, Dowd CF, et al. Accuracy of selective venous sampling for intact parathyroid hormone in difficult patients with recurrent or persistent hyperparathyroidism. Surgery. 2002;132:944–50. discussion 950-941.PubMedCrossRef
41.
Wei B, Inabnet W, Lee JA, et al. Optimizing the minimally invasive approach to mediastinal parathyroid adenomas. Ann Thorac Surg. 2011;92:1012–7.PubMedCrossRef
42.
Yamada T, Ikuno M, Shinjo Y, et al. Selective venous sampling for primary hyperparathyroidism: how to perform an examination and interpret the results with reference to thyroid vein anatomy. Jpn J Radiol. 2017;35:409–16.PubMedCrossRef
43.
Gofrit ON, Lebensart PD, Pikarsky A, et al. High-resolution ultrasonography: highly sensitive, specific technique for preoperative localization of parathyroid adenoma in the absence of multinodular thyroid disease. World J Surg. 1997;21(3):287–91.PubMedCrossRef
44.
Papavramidis TS, Polyzonis M, Pliakos I, et al. Intrathyroid parathyroid adenoma: should preoperative imaging tests help guiding scheduled operation? Report of two cases. Ann Thyroid Res. 2014;1(2):23–6.
45.
Pliakos I, Chorti A, Moysidis M, et al. Parathyroid adenoma in pregnancy: a case report and systematic review of the literature. Front Endocrinol (Lausanne). 2022;13:975954.PubMedCrossRef
46.
Levine DS, Wiseman SM. Fusion imaging for parathyroid localization in primary hyperparathyroidism. Expert Rev Anticancer Ther. 2010;10:353–63.PubMedCrossRef
47.
Taterra D, Wong LM, Vikse J, et al. The prevalence and anatomy of parathyroid glands: a meta-analysis with implications for parathyroid surgery. Langenbecks Arch Surg. 2019;404:63–70.PubMedPubMedCentralCrossRef
48.
Gimm O, Arnesson LG, Olofsson P, et al. Super-selective venous sampling in conjunction with quickPTH for patients with persistent primary hyperparathyroidism: report of five cases. Surg Today. 2012;42:570–6.PubMedCrossRef
49.
Hamdy NA. A patient with persistent primary hyperparathyroidism due to a second ectopic adenoma. Nat Clin Pract Endocrinol Metab. 2007;3:311–5.PubMedCrossRef
50.
Wiedmann M, Kassahun W, Deckert F, et al. 65-year old female patient with persistent hypercalcemia. Internist (Berl). 2007;48:1436–41.PubMedCrossRef
51.
Ogilvie CM, Brown PL, Matson M, et al. Selective parathyroid venous sampling in patients with complicated hyperparathyroidism. Eur J Endocrinol. 2006;155:813–21.PubMedCrossRef
52.
Morbois-Trabut L, Saad N, Gervaise N, et al. Diagnostic strategy in persistent hyperparathyroidism report of two cases and review of the literature. Ann Endocrinol (Paris). 2002;63:18–22.PubMed
53.
Saky MT, Hasinski S, Rose LI. Ectopic primary hyperparathyroidism. Endocr Pract. 2001;7:272–4.PubMed
54.
Nilsson BE, Tisell LE, Jansson S, et al. Parathyroid localization by catheterization of large cervical and mediastinal. World J Surg. 1994;18:605–10.PubMedCrossRef
55.
Iwasaki A, Sekihara T, Yoshioka T, et al. Ectopic parathyroid adenoma: a case report. Hinyokika Kiyo. 1991;37:557–61.PubMed
56.
Kitamura T, Ueno A, Tanaka M, et al. Parathyroid adenoma found by vertebral vein sampling. J Urol. 1980;123:940–2.PubMedCrossRef
57.
Favere AM, Tsukumo DM, Matos PS, et al. Association between atypical parathyroid adenoma and neurofibromatosis. Arch Endocrinol Metab. 2015;59:460–6.PubMedCrossRef
58.
Behera KK, Nanaiah A, Gupta A, et al. Neurofibromatosis type 1, pheochromocytoma with primary hyperparathyroidism: a rare association. Indian J Endocrinol Metab. 2013;17:349–51.PubMedPubMedCentralCrossRef
59.
Calcaterra TC, Rich JR, Ward PW. Neurilemmoma of the sphenoid sinus. Arch Otolaryngol. 1974;100:383–5.PubMedCrossRef
Metadata
Title
Selective venous sampling in primary hyperparathyroidism caused by ectopic parathyroid gland: a case report and literature review
Authors
Xubin Yang
Xueyan Chen
Huan Xu
Junwei Chen
Bin Yao
Qiongyan Lin
Hongrong Deng
Wen Xu
Publication date
06-07-2023
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2023
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-023-01376-5

Other articles of this Issue 1/2023

BMC Endocrine Disorders 1/2023 Go to the issue

Research

The association between healthy beverage index and sarcopenic obesity among women with overweight and obesity: a cross-sectional study

Research

Serum prolactin and gonadal hormones in hemodialysis women: a meta-analysis

Research

Vitamin D deficiency increases with age and adiposity in Emirati children and adolescents irrespective of type 1 diabetes mellitus: a case control study

Research

The outcomes of transcatheter adrenal ablation in patients with primary aldosteronism: a systematic review and meta-analysis

Case report

PBAH complicated by cryptococcal infection

Research

Associations of polyunsaturated fatty acids with cardiovascular disease and mortality: a study of NHANES database in 2003–2018
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits